Sale and provision of injectable contraceptives in drug shops in developing countries: conclusions from a technical consultation

Contraception. 2015 Feb;91(2):93-6. doi: 10.1016/j.contraception.2014.11.007. Epub 2014 Nov 15.

Authors

John Stanback¹, Elena Lebetkin², Tracy Orr², Shawn Malarcher³; Family Planning Provision in Drug Shops Technical Consultation Participants

Collaborators

Family Planning Provision in Drug Shops Technical Consultation Participants:
Christine Bixiones, Bettina Brunner, Dawn Chin-Quee, Victoria Graham, Mihira Karra, Elena Lebetkin, Jessica Levy, Rachel Lieber, Shawn Malarcher, Maggwa Ndugga, Tracy Orr, Kristen Shellenberg, Ilene Speizer, John Stanback, Sara Stratton

Affiliations

¹ FHI 360. Electronic address: jstanback@fhi360.org.
² FHI 360.
³ US Agency for International Development.

PMID: 25604899
DOI: 10.1016/j.contraception.2014.11.007

No abstract available

Publication types

Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Community Pharmacy Services*
Congresses as Topic
Consensus Development Conferences as Topic
Contraceptive Agents, Female / administration & dosage*
Contraceptive Agents, Female / adverse effects
Contraceptive Agents, Female / economics
Developing Countries*
Drug Implants
Evidence-Based Medicine*
Family Planning Policy
Family Planning Services* / education
Family Planning Services* / standards
Female
Health Priorities
Health Services Accessibility*
Humans
Male
Medroxyprogesterone Acetate / administration & dosage*
Medroxyprogesterone Acetate / adverse effects
Medroxyprogesterone Acetate / economics
Patient Education as Topic
Practice Guidelines as Topic
United States
United States Agency for International Development
Voluntary Health Agencies

Substances

Contraceptive Agents, Female
Drug Implants
Medroxyprogesterone Acetate